BRAIN DISORDER MEDICATIONS
250 mg Temoside 250 Temozolomide IP Capsules
Price on Request
Temoside 250 mg (Temozolomide IP) is an oral chemotherapy capsule manufactured by Cipla. It is primarily prescribed to treat aggressive brain cancers, such as glioblastoma multiforme and anaplastic astrocytoma. It functions as an alkylating agent that targets and damages cancer cell DNA, hindering their growth and replication.
liketo,usa.uk.china.southkorea.russia.japan.singapore
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Strength 250 mg
Brand Temoside 250
Capsules per Pack 5 Capsules
Form Capsule
Usage Cancer Care, Brain Tumor
Manufacturer Cipla
Prescription/Non prescription Prescription
Country of Origin Made in India
Pack Type Bottle
Brand Name Temoside
Product Form Capsules
Pack Size 1*5 Capsules
Composition Temozolomide Capsules IP
Dose 250mg/100mg/20mg
Minimum order quantity: 50 Bottle
Enquire About This Product
